- Home
- EPM vs VIGL Comparison
EPM vs VIGL Comparison
Compare EPM & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPM
- VIGL
- Stock Information
- Founded
- EPM 2003
- VIGL 2020
- Country
- EPM United States
- VIGL United States
- Employees
- EPM N/A
- VIGL N/A
- Industry
- EPM Oil & Gas Production
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- EPM Energy
- VIGL Health Care
- Exchange
- EPM Nasdaq
- VIGL Nasdaq
- Market Cap
- EPM 171.8M
- VIGL 148.7M
- IPO Year
- EPM 1996
- VIGL 2022
- Fundamental
- Price
- EPM $5.52
- VIGL $3.50
- Analyst Decision
- EPM Strong Buy
- VIGL Buy
- Analyst Count
- EPM 1
- VIGL 5
- Target Price
- EPM $8.25
- VIGL $16.60
- AVG Volume (30 Days)
- EPM 316.1K
- VIGL 81.3K
- Earning Date
- EPM 09-10-2024
- VIGL 11-05-2024
- Dividend Yield
- EPM 8.44%
- VIGL N/A
- EPS Growth
- EPM N/A
- VIGL N/A
- EPS
- EPM 0.12
- VIGL N/A
- Revenue
- EPM $85,877,000.00
- VIGL N/A
- Revenue This Year
- EPM $28.11
- VIGL N/A
- Revenue Next Year
- EPM N/A
- VIGL N/A
- P/E Ratio
- EPM $46.75
- VIGL N/A
- Revenue Growth
- EPM N/A
- VIGL N/A
- 52 Week Low
- EPM $4.59
- VIGL $2.47
- 52 Week High
- EPM $7.07
- VIGL $9.24
- Technical
- Relative Strength Index (RSI)
- EPM 62.41
- VIGL 47.46
- Support Level
- EPM $5.37
- VIGL $3.43
- Resistance Level
- EPM $5.82
- VIGL $3.83
- Average True Range (ATR)
- EPM 0.21
- VIGL 0.27
- MACD
- EPM 0.09
- VIGL -0.00
- Stochastic Oscillator
- EPM 90.39
- VIGL 36.14
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent oil and gas company operating in the US. It is engaged primarily in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are primarily generated from its crude oil, natural gas and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana. The revenue generated by the company includes royalty, mineral and working interests.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.